| – | Stage 1 (n=42) | Stage 2 (n=14) | Stage 3 (n=4) | p |
|---|---|---|---|---|
| Ages | 67.19 ± 17.51 | 64.21 ± 11.24 | 70.00 ± 17.39 | 0.769 |
| Number of male | 20 (47.6) | 9 (64.3) | 2 (50) | 0.556 |
| Urea(mmol/l) | 9.2 (6.9 – 12.72) |
17.15 (9.5 – 21.32) |
32.45 (26.92 – 62.42) |
0.001* |
| Serum creatinine (µmol/l) | 159.5 (147 – 181.25) |
285.5 (248.75 – 323) |
469.5 (442.75 – 528.5) |
0.001* |
| Serum NGAL (ng/ml) | 315.19 (249.42 – 421.47) |
679.02 (601.84 – 770.48) |
806.64 (725.03 – 878.25) |
0.001* |
| Hospital Mortality (n,%) | 5 (11.9) | 4 (28.6) | 3 (75) | 0.007* |